Medicare Lab Payment Cuts Spark Bipartisan Concern Over Patient Access
Event summary
- 96% of voters surveyed consider diagnostic lab tests important to their care, with 75% calling them 'very important'.
- 83% of voters relied on a diagnostic lab test in the past two years to help a doctor make a medical decision.
- 93% of voters likely to support congressional candidates who protect Medicare patients' access to diagnostic testing.
- The RESULTS Act, with 130 congressional sponsors, aims to stabilize Medicare lab payment rates and prevent cuts.
- Scheduled Medicare lab payment cuts of up to 15% begin January 1, 2027, with further reductions planned for 2028 and 2029.
The big picture
The scheduled Medicare lab payment cuts under PAMA threaten access to essential diagnostic testing, particularly for vulnerable populations. The bipartisan RESULTS Act aims to stabilize rates, reflecting broad concern across the healthcare industry. Quest Diagnostics' survey underscores the critical role of lab testing in patient care, highlighting the potential consequences of payment reductions.
What we're watching
- Legislative Momentum
- Whether Congress will pass the RESULTS Act before the January 2027 cuts take effect, given bipartisan support.
- Patient Impact
- How Medicare seniors, rural communities, and chronic disease patients will be affected by potential lab payment cuts.
- Industry Advocacy
- The effectiveness of Quest Diagnostics and ACLA's lobbying efforts to prevent destabilizing rate cuts.